Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

A review of twenty AML patients who were treated with azacitidine demonstrated a response rate of 60% and for those that responded, a median survival of 15+ months.

Outpatient Azacitidine for Selected AML Patients